Legend Biotech (LEGN) Short-term Investments (2019 - 2026)

Legend Biotech (LEGN) has 6 years of Short-term Investments data on file, last reported at $70000.0 in Q2 2025.

• Quarterly Short-term Investments rose 100.05% year-over-year to $70000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $70000.0 (up 100.05% YoY) and the FY2024 annual result came in at $70000.0, down 89.44% from the prior year.
• Short-term Investments was little changed at $70000.0 in Q2 2025, from $70000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $185.8 million in Q3 2023 to a low of -$160.0 million in Q3 2022.
• A 5-year average of $14.6 million and a median of $70000.0 in 2024 frame the typical range for Short-term Investments.
• The widest YoY moves for Short-term Investments: up 471.21% in 2022, down 419.74% in 2022.
• Tracing LEGN's Short-term Investments over 5 years: stood at -$50.0 million in 2021, then soared by 471.21% to $185.6 million in 2022, then tumbled by 99.64% to $663000.0 in 2023, then slumped by 89.44% to $70000.0 in 2024, then changed by 0.0% to $70000.0 in 2025.
• The last three Short-term Investments figures came in at $70000.0 (Q2 2025), $70000.0 (Q1 2025), and $70000.0 (Q4 2024), per Business Quant data.